Intellia Therapeutics, Inc. (NASDAQ:NTLA) Stock Has Consensus Price Target of $20.98 According to Brokerages
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has received a consensus recommendation of “Hold” from the twenty-three brokerages that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation, ten have given a buy recommendation and one has assigned […]
25 Sep 05:58 · The Markets Daily